Skip to main content
Fig. 5 | Pediatric Rheumatology

Fig. 5

From: Factors associated with reduced infliximab exposure in the treatment of pediatric autoimmune disorders: a cross-sectional prospective convenience sampling study

Fig. 5

Association between estimated IFX clearance and disease activity. Estimated IFX clearance values are stratified and presented based on disease activity by (a) cJADAS-71 for patients with JIA and (b) by PGA for patients with IBD. Data is plotted as box and whisker plots and evaluated by unpaired analysis using the Wilcoxon rank-sum test and the resulting p-values are provided

Back to article page

Pediatric Rheumatology

ISSN: 1546-0096